CCMINC
HAE icon

Cardinal Capital Management Inc (North Carolina)’s Haemonetics HAE Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
24,817
+917
+4% +$58.9K 0.23% 114
2026
Q1 		$1.35M Buy
23,900
+1,458
+6% +$95K 0.17% 119
2025
Q4 		$1.8M Buy
22,442
+321
+1% +$21.6K 0.24% 105
2025
Q3 		$1.08M Buy
22,121
+1,652
+8% +$102K 0.15% 122
2025
Q2 		$1.53M Buy
20,469
+654
+3% +$43.3K 0.22% 109
2025
Q1 		$1.26M Buy
19,815
+1,531
+8% +$104K 0.2% 117
2024
Q4 		$1.43M Buy
18,284
+935
+5% +$75.1K 0.22% 111
2024
Q3 		$1.39M Buy
17,349
+2,517
+17% +$203K 0.22% 112
2024
Q2 		$1.23M Buy
14,832
+549
+4% +$48.3K 0.21% 111
2024
Q1 		$1.22M Buy
14,283
+2,994
+27% +$235K 0.2% 116
2023
Q4 		$965K Buy
11,289
+101
+0.9% +$8.73K 0.18% 116
2023
Q3 		$1M Buy
11,188
+286
+3% +$25.5K 0.2% 111
2023
Q2 		$928K Buy
10,902
+123
+1% +$10.4K 0.19% 112
2023
Q1 		$892K Sell
10,779
-1
-0% -$81 0.19% 113
2022
Q4 		$848K Buy
10,780
+238
+2% +$19.1K 0.18% 116
2022
Q3 		$780K Buy
10,542
+337
+3% +$24.2K 0.18% 114
2022
Q2 		$665K Buy
10,205
+568
+6% +$33.6K 0.15% 124
2022
Q1 		$609K Buy
9,637
+1,516
+19% +$82.4K 0.12% 130
2021
Q4 		$431K Buy
8,121
+293
+4% +$17.9K 0.09% 135
2021
Q3 		$553K Buy
7,828
+761
+11% +$48K 0.12% 129
2021
Q2 		$471K Sell
7,067
-1,089
-13% -$77.1K 0.1% 132
2021
Q1 		$905K Buy
8,156
+88
+1% +$10.9K 0.2% 113
2020
Q4 		$958K Buy
8,068
+196
+2% +$21.1K 0.23% 106
2020
Q3 		$687K Buy
7,872
+311
+4% +$27.2K 0.19% 103
2020
Q2 		$677K Buy
7,561
+431
+6% +$43.5K 0.19% 109
2020
Q1 		$710K Sell
7,130
-797
-10% -$86.4K 0.23% 98
2019
Q4 		$911K Sell
7,927
-109
-1% -$13.2K 0.24% 102
2019
Q3 		$1.01M Sell
8,036
-66
-0.8% -$8.38K 0.28% 94
2019
Q2 		$975K Sell
8,102
-158
-2% -$15.5K 0.28% 94
2019
Q1 		$722K Buy
8,260
+160
+2% +$14.6K 0.21% 109
2018
Q4 		$810K Buy
8,100
+163
+2% +$17.1K 0.27% 93
2018
Q3 		$909K Buy
7,937
+39
+0.5% +$4.04K 0.26% 100
2018
Q2 		$708K Buy
7,898
+91
+1% +$7.68K 0.21% 109
2018
Q1 		$571K Sell
7,807
-7,072
-48% -$485K 0.18% 105
2017
Q4 		$864K Sell
14,879
-150
-1% -$7.9K 0.26% 93
2017
Q3 		$674K Buy
15,029
+1,363
+10% +$56.6K 0.21% 103
2017
Q2 		$540K Buy
13,666
+1,893
+16% +$77.7K 0.18% 104
2017
Q1 		$478K Buy
11,773
+193
+2% +$7.54K 0.17% 104
2016
Q4 		$466K Buy
11,580
+1,664
+17% +$62.7K 0.18% 103
2016
Q3 		$359K Buy
9,916
+1,010
+11% +$34.7K 0.14% 105
2016
Q2 		$258K Buy
8,906
+659
+8% +$19.9K 0.1% 114
2016
Q1 		$288K Buy
+8,247
New +$266K 0.12% 114
2015
Q4 		– Sell
-7,337
Closed -$237K – 120
2015
Q3 		$237K Buy
7,337
+971
+15% +$36.5K 0.11% 111
2015
Q2 		$263K Buy
6,366
+1,219
+24% +$51.4K 0.11% 112
2015
Q1 		$231K Buy
+5,147
New +$215K 0.1% 113

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s HAE Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) increased its Haemonetics (HAE) stake by 3.8% in Q2 2026, buying an estimated $58.9K and bringing the position to 24,817 shares worth $1.86M. The position accounts for 0.23% of the portfolio, ranked #114.

Cardinal Capital Management Inc (North Carolina) first reported a position in HAE in Q1 2015 and has held it in 45 quarters since. 136 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 24,817 shares of Haemonetics worth $1.86M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) bought 917 Haemonetics shares in Q2 2026, an estimated $58.9K.
  • Haemonetics made up 0.23% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #114 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Haemonetics in Q1 2015 and has held it in 45 quarters since.
  • 136 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.